AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05097560 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Venturi mask
Description: VM is commonly used by COPD patients during exercise training.
Study NCT05760833 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ablation
Description: Ablation of either the pulmonary veins or the atrioventricular node
Study NCT04802291 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HomeStyles-2: Obesity Prevention Program for Families with Children in Middle Childhood
Description: Comparison of 2 educational interventions
Study NCT04802291 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HomeStyles-2: Obesity Prevention Program for Families with Children in Middle Childhood
Description: Comparison of 2 educational interventions
Study NCT05279443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: yoga-based exercises therapy
Description: Accompanied by a certified yoga instructor, and under the supervision of an PMR specialist and a Sports Medicine specialist, YBEs were administered to our patients included in the study for 8 weeks, 2 sessions a week, and with sessions of 60 minutes, using personal mats and equipment in a 2475 m3 (18mx25mx5.5m) gym area that belonged to our hospital, in the form of group therapy for 5 (five) people and in accordance with the social distancing rules. The exercises program was applied as a exercise program consisting of physical postures (asana) to improve the body's muscle strength and flexibility, breathing exercises (pranayama) to increase respiratory function, and relaxation and meditation (dhyana) techniques.
Study NCT05125757 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lifestyle modification
Description: for 12 week, the patients of this group will receive their usual immuno-modulating therapy plus life style modification (energy or diet restriction in addition to daily walking, 15000 steps)
Study NCT05125757 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: usual lifestyle
Description: the patients will receive the usual immuno-modulating therapy with continued usual diet and activities
Study NCT06229197 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Billroth II reconstruction
Description: Billroth II reconstruction, in which a loop of jejunum is mobilized and anastomosed to the gastric remnant
Study NCT06229197 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Billroth II reconstruction
Description: Billroth II reconstruction, in which a loop of jejunum is mobilized and anastomosed to the gastric remnant
Study NCT06229197 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Braun Anastomosis
Description: This is an additional surgical connection (anastomosis) created between two parts of the small intestine, specifically between the afferent (incoming) and efferent (outgoing) limbs of the jejunum near the gastrojejunostomy (the new connection between the stomach and small intestine created during a Billroth II procedure).
Study NCT05578456 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone and Aspirin
Description: prednisone 10 mg and aspirin 75-100mg per day per os
Study NCT05578456 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo 2 starch tablets per day per os
Study NCT06450795 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Participants in both groups will then receive PTKE treatment for 8 weeks, 3 days a week for 30-45 minutes, under the supervision of specialist physiotherapists.
Description: HIFEM treatment for 6 weeks, 2 days a week for 28 minutes. The evaluations will be repeated at the end of the treatment.
Study NCT06030804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: A loading dose of dexmedetomidine (0.6 μg/kg) will be administered over 10-15 minutes before anaesthesia induction, followed by a continuous infusion at a rate of 0.5 μg/kg/hr till 1 hour before the end of surgery. Patient-controlled dexmedetomidine supplemented sufentanil analgesia will be provided after surgery: the formula contains a mixture of sufentanil (1.25 μg/ml) and dexmedetomidine (1.25 μg/ml), diluted with normal saline to a total volume of 160 ml; the analgesic pump is set to administer a background infusion at a rate of 1 ml/h, with patient-controlled bolus of 2 ml each time and a lockout time of 8 minutes.
Study NCT06030804 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Volume-matched normal saline will be administered in the same rate and volume for the same duration as in the dexmedetomidine group during anesthesia. Patient-controlled sufentanil analgesia will be provided after surgery: the formula contains sufentanil (1.25 μg/ml), diluted with normal saline to a total volume of 160 ml; the analgesic pump is set to administer a background infusion at a rate of 1 ml/h, with patient-controlled bolus of 2 ml each time and a lockout time of 8 minutes.
Study NCT04832789 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Venovenous ECMO
Description: Venovenous ECMO
Study NCT05906472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Feeds continued
Description: Enteral feeds are continued up until time of surgery
Study NCT05906472 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Feeds held
Description: Enteral feeds are stopped 6 or more hours before surgery
Study NCT05337982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Downhill Eccentric Treadmill Training with Electrical Stimulation
Description: Participants will walk on a treadmill with a downward incline with support from a harness and assistance from trainers as needed. Participants will also simultaneously receive stimulation to their muscles including their trunk and legs. Each session will include 20 minutes of walking divided into 5 minute bouts with 5 minute rest breaks in between for 3 sessions per week for 12 weeks.
Study NCT06405438 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention.
Study NCT04152668 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Titanium curette.
Description: Implant debridement.
Study NCT04152668 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Titanium curette.
Description: Implant debridement.
Study NCT04152668 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonic
Description: Implant debridement.
Study NCT04152668 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasonic
Description: Implant debridement.
Study NCT04152668 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Air-polishing
Description: Implant debridement and polishing.
Study NCT04856969 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olmesartan
Description: First stage: ATB-1011 for 5days, repeated administration, Second stage: ATB-1012 + ATB-1011 for 5days, repeated administration
Study NCT04856969 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: First stage: ATB-1012 for 5days, repeated administration, Second stage: ATB-1012 + ATB-1011 for 5days, repeated administration
Study NCT05799911 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydrogen rich water
Description: Hydrogen-rich water with molecular hydrogen concentration 0.9 ppm.
Study NCT05799911 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tap water with molecular hydrogen concentration 0.0 ppm.
Study NCT04876404 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PET/MR Imaging
Description: The hybrid PET/MR scanner can provide information on brain activity during various motor and cognitive tasks.
Study NCT06444854 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: early chest tube removal
Description: Chest tube removal
Study NCT05230446 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PCI with OCT guidance
Description: Procedure will be optimize using pre-and post-stent OCT imaging, to improve the accuracy of stent placement and reduce geographic miss, but also to prevent malapposition of the stent and to discover dissections.
Study NCT05237505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bi-level positive pressure non invasive ventilation
Description: Participants randomized to the bi-level arm will be provided with an auto bi-level device that automatically delivers the required pressure. The settings in the auto bi-level will be minimum EPAP of 4 cmH2O, maximum IPAP of 24 cmH2O, and a range of pressure support between 6-10 cmH2O. For those participants who have been randomized to the bi-level group but have not successfully acclimated to the device with the automatic bi-level settings, we will conduct an in-lab titration of the bi-level therapy during the optional Overnight visit 2.
Study NCT05237505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxygen gas
Description: The dose of nocturnal oxygen in all participants in the oxygen therapy arm will be 2 liters/minute. Patients with daytime hypoxemia, measured as sustained desaturations below 89% during wake time and/or arterial blood PO2 ≤ 55 mmHg, will be excluded from this study (as specified in the exclusion criteria) for ethical reasons since withholding oxygen in hypoxemic patients would be at odds with standard of care.
Study NCT06203392 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Very low carbohydrate ketogenic diet
Description: Very low carbohydrate ketogenic diet provided for six weeks
Study NCT06203392 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet
Description: Mediterranean diet provided for six weeks
Study NCT05306665 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT intervention
Description: One day in person workshop + telephone booster
Study NCT05096273 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ReACT
Description: ReACT is a novel cognitive behavioral treatment and is a PNES intervention that targets sense of control and catastrophic symptom expectations
Study NCT05096273 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ReACT
Description: ReACT is a novel cognitive behavioral treatment and is a PNES intervention that targets sense of control and catastrophic symptom expectations
Study NCT05464940 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous caffeine
Description: Group assigned to receive caffeine will receive intravenous(IV) caffeine and sodium benzoate infusion starting at 250-500 mg.~This method will use an automated algorithm that adjusts the flow of the infusion depending on the individual's sex and weight and then in a serial fashion in response to blood caffeine measurements. Serial blood caffeine measurements at pre-determined intervals according to the algorithm will be until a steady state is obtained.
Study NCT05464940 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Masked Placebo
Description: The patients assigned to the masked placebo will receive 5% dextrose in 0.45% saline using the same infusion protocol for a random length of time that was within 1 standard deviation(SD) of the mean time to achieve a steady state using the caffeine protocol (17+4 min).~To maintain blinding, caffeine blood concentration measurements that will be randomly generated within 2 SDs of the predicted values calculated by the algorithm will be used and verbally communicated for placebo infusions.
Study NCT05310123 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: AC-11
Description: 6-months of treatment with AC-11
Study NCT04638530 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Education on breaking bad news to family members remotely
Description: Participants will receive a combination of surveys, pre- and post-tests, lectures and didactics to increase their awareness of techniques to communicate difficult topics with patients remotely as well as skill building exercises.
Study NCT04709835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AT-527
Description: Results from Arm AT-527 500 mg determined the dose and regimen to be used for AT-527 1100 mg.
Study NCT04709835 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The dose and regimen of the placebo will match that of the respective AT-527 comparator arm.
Study NCT05700370 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MyProstateScore
Description: MyProstateScore is a urine-based biomarker test used to predict the risk of clinically significant prostate cancer
Study NCT05475886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.4
Description: An initial infusion dose of 500 ml 6% Hydroxyethyl starch (130/0.4) coload simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 100 ml according to the responses of previous patients according to the up-down sequential allocation.
Study NCT06132932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WX390
Description: Participants will receive WX390 1.1 mg tablet orally once a day for a continuous 28-day cycle.
Study NCT05965076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Glycine Perio Flow
Description: Professional plaque and tartar removal by means of titanium curettes, bridge and implant floss and glycine perio-flow.
Study NCT05965076 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Angled Toothbrush
Description: Patients will be educated and motivated in domiciliary oral hygien by means of bridge and implant floss and an angled toothbrush.
Study NCT05965076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard Professional Oral Hygiene
Description: Professional plaque and tartar removal by means of titanium curettes, bridge and implant floss.
Study NCT05965076 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Professional Oral Hygiene
Description: Professional plaque and tartar removal by means of titanium curettes, bridge and implant floss.
Study NCT05965076 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Domiciliary Oral Hygiene
Description: Patients will be educated and motivated in domiciliary oral hygien by means of bridge and implant floss and a standard toothbrush.
Study NCT05965076 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Domiciliary Oral Hygiene
Description: Patients will be educated and motivated in domiciliary oral hygien by means of bridge and implant floss and a standard toothbrush.
Study NCT03702062 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 6 Minute Walk Test Smart phone Application
Description: The intervention requests participants to user the smart phone application at prescribed frequencies during the follow-up period.
Study NCT05153603 — intervention group
Intervention type: DRUG
Intervention: Olaparib mono-maintenance therapy
Description: Olaparib mono-maintenance therapy in patients with newly diagnosed, histologically confirmed, advanced (FIGO stage III-IV) ovarian cancer, primary peritoneal cancer and / or fallopian-tube cancer is defined as drug exposure. At least one dose of olaparib tablets monotherapy as maintenance therapy will be required.
Study NCT04819724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 3D motion analysis
Description: 30° arm abduction in the scapular plane will be performed with and without a handheld weight of 1, 2, 3, and 4 kg. All movements will be done bilaterally. Electromyographic (EMG) data of arm and trunk muscles will be recorded using surface electrodes. Participants will be asked to perform full arm abduction with different rotations (internal, neutral and external rotation), flexion and internal-/external rotations movements (without additional handheld weight).
Study NCT04819724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: isometric shoulder strength by dynamometer
Description: isometric shoulder strength for abduction and internal/external rotation will be assessed with a isometric shoulder strength for abduction and internal/external rotation will be assessed with a dynamometer
Study NCT04819724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: fluoroscopic images of each shoulder
Description: fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)
Study NCT04819724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Bilateral shoulder Magnetic Resonance Imaging (MRI)
Description: MRI of both shoulders will be taken
Study NCT04819724 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: data collection by health questionnaires
Description: data collection by health questionnaires
Study NCT05742789 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Propofol
Description: To maintain anaesthesia in Group 1 P, propofol was used as an anaesthetic in a dose of 4-6 mg/kg/h intravenously on a perfusor
Study NCT05742789 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Isoflurane
Description: В качестве анестетика использовали изофлуран - 1,1-1,2 MAC.
Study NCT05742789 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sevoflurane
Description: в качестве анестетика использовали севофлуран в дозе - 1,7-1,9 ПДК.
Study NCT05120128 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acuvue® Oasys 1-Day
Description: TEST Lens
Study NCT06499311 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Reflexology
Description: Foot Reflexology is an alternative medical practice involving the application of pressure to specific points on the feet. It has been reported as a non-invasive complementary therapy that was addressed as an effective technique that is reported to reduce premenstrual symptoms.
Study NCT06499311 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: Acupressure is a sort of massage therapy, was addressed as an effective technique that is reported to reduce premenstrual symptoms. Acupressure is a well-known form of Traditional Chinese Medicine that is a component of alternative treatments.
Study NCT05124028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib
Description: 50mg po qd 6 weeks
Study NCT05833854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality glasses group
Description: It is suggested that the use of virtual reality glasses during the injection will positively affect the pain and fear levels in children who received penicillin injection in the pediatric emergency department where the study was conducted.
Study NCT05833854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual pressure group
Description: In the pediatric emergency department where the study was conducted, pressure will be applied to the area to be injected for 10 seconds before the injection procedure in children who received penicillin injection. Pressing with the thumb of the hand, which will be passive in the pressing application, will be understood by the whitening of the nail, and thus pressure will be applied to the skin. It is suggested that it can positively affect pain and fear levels.
Study NCT05043506 — intervention group
Intervention type: DRUG
Intervention: Palbociclib + aromatase inhibitor
Description: Palbociclib + an aromatase inhibitor therapy
Study NCT05043506 — intervention group
Intervention type: DRUG
Intervention: Aromatase inhibitor
Description: Aromatase inhibitor monotherapy
Study NCT05037708 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage
Description: Subjects are randomly assigned to group 1. Group 1 receives treatment A\* for 4 weeks.~Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B\*\* was applied to group 1 for 4 weeks.~\*Treatment A consists of manual lymphatic drainage.~\*\*Treatment B consists of no treatment
Study NCT05037708 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual lymphatic drainage
Description: Subjects are randomly assigned to group 2. Group 2 receives treatment B\*\* for 4 weeks.~Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A\* was applied to group 2 for 4 weeks.~\*Treatment A consists of manual lymphatic drainage.~\*\*Treatment B consists of no treatment
Study NCT05812898 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: exercises
Description: strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles
Study NCT05812898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises
Description: strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles
Study NCT05812898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myofascial release
Description: myofascial release using instrument assisted soft tissue mobilization
Study NCT06384768 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video training
Description: A 4 week support program consist of videos for fear of childbirth